Establishment of shared antigen reactive cytotoxic T lymphocyte using co-stimulatory molecule introduced autologous cancer cells

Experimental and Molecular Pathology

Volumn 88, Issue 1, 2010, Pages 128-132

  Hirohashi, Yoshihiko ^a,b   Torigoe, Toshihiko ^a   Hirai, Itaru ^a   Tamura, Yasuaki ^a   Nakatsugawa, Munehide ^a   Inoue, Yuuji ^c   Kanaseki, Takayuki ^a   Kamiguchi, Kenjiro ^a   Ikeda, Hideyuki ^a   Sasaki, Aya ^a   Yamanaka, Noboru ^b   Sato, Noriyuki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^c Sapporo Respiratory Medicine Hospital   (Japan)

Author keywords

Adenocarcinoma; B7.1 (CD80); CTL; HLA A24; Lung cancer; Tolerance

Indexed keywords

B7 ANTIGEN; HLA A24 ANTIGEN;

AGED; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; CANCER CELL CULTURE; CASE REPORT; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; LUNG ADENOCARCINOMA; MALE; MELANOMA; STOMACH CARCINOMA; TUMOR IMMUNITY;

ADENOCARCINOMA; AGED; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD80; ANTIGENS, NEOPLASM; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; HLA-A ANTIGENS; HUMANS; IMMUNE TOLERANCE; LUNG NEOPLASMS; MALE; MELANOMA; STOMACH NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 74749083042     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2009.09.021     Document Type: Article

References (22)

1. Boon T., et al. Tumor antigens recognized by T cells. Immunol. Today 18 (1997) 267-268
2. Chen L., et al. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71 (1992) 1093-1102
3. Gilligan M.G., et al. Adenoviral delivery of B7-1 (CD80) increases the immunogenicity of human ovarian and cervical carcinoma cells. Gene Ther. 5 (1998) 965-974
4. Hirohashi Y., et al. The functioning antigens: beyond just as the immunological targets. Cancer Sci. 100 (2009) 798-806
5. Kashiwagi K., et al. Analysis of a shared pancreatic cancer antigen recognized by an HLA-A*2601-restricted cytotoxic T-lymphocyte clone. Pancreas 26 (2003) e81-e88
6. Kaufmann A.M., et al. Expression of CD80 enhances immunogenicity of cervical carcinoma cells in vitro. Cell Immunol. 169 (1996) 246-251
7. Kobayashi J., et al. Clonal diversity of cytotoxic T lymphocytes that recognize autologous oral squamous cell carcinoma. Hum. Immunol. 70 (2009) 89-95
8. Liu Y., and Janeway Jr. C.A. Interferon gamma plays a critical role in induced cell death of effector T cell: a possible third mechanism of self-tolerance. J. Exp. Med. 172 (1990) 1735-1739
9. Maeda A., et al. Identification of human antitumor cytotoxic T lymphocytes epitopes of recoverin, a cancer-associated retinopathy antigen, possibly related with a better prognosis in a paraneoplastic syndrome. Eur. J. Immunol. 31 (2001) 563-572
10. Marchand M., et al. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int. J. Cancer 80 (1999) 219-230
11. Miyazaki A., et al. Cytotoxicity of histocompatibility leukocyte antigen-DR8-restricted CD4 killer T cells against human autologous squamous cell carcinoma. Jpn. J. Cancer Res. 88 (1997) 191-197
12. Miyazono Y., et al. Effect of B7.1-transfected human colon cancer cells on the induction of autologous tumour-specific cytotoxic T cells. J. Gastroenterol. Hepatol. 14 (1999) 997-1003
13. Nabeta Y., et al. Recognition by cellular and humoral autologous immunity in a human osteosarcoma cell line. J. Orthop. Sci. 8 (2003) 554-559
14. Rosenberg S.A. A new era for cancer immunotherapy based on the genes that encode cancer antigens. Immunity 10 (1999) 281-287
15. Rosenberg S.A., et al. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat. Med. 4 (1998) 321-327
16. Schwartz R.H. A cell culture model for T lymphocyte clonal anergy. Science 248 (1990) 1349-1356
17. Takenoyama M., et al. Successful induction of tumor-specific cytotoxic T lymphocytes from patients with non-small cell lung cancer using CD80-transfected autologous tumor cells. Jpn. J. Cancer Res. 92 (2001) 309-315
18. Townsend S.E., and Allison J.P. Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. Science 259 (1993) 368-370
19. Ueda D., et al. T-cell receptor gene structures of HLA-A26-restricted cytotoxic T lymphocyte lines against human autologous pancreatic adenocarcinoma. Jpn. J. Cancer Res. 86 (1995) 691-697
20. Wroblewski J.M., et al. Characterization of human non-small cell lung cancer (NSCLC) cell lines for expression of MHC, co-stimulatory molecules and tumor-associated antigens. Lung Cancer 33 (2001) 181-194
21. Yang S., et al. Generation of primary tumor-specific cytotoxic T lymphocytes from autologous and human lymphocyte antigen class I-matched allogeneic peripheral blood lymphocytes by B7 gene-modified melanoma cells. Cancer Res. 57 (1997) 1561-1568
22. Yasoshima T., et al. The mechanism of human autologous gastric signet ring cell tumor rejection by cytotoxic T lymphocytes in the possible context of HLA-A31 molecule. Cancer 75 (1995) 1484-1489